Top Growth Opportunities
Opportunities for Biologics Contract Development and Manufacturing Organizations
- How are recent mergers, acquisitions, and biotechnology financing megatrends shaping biologics development?
- Are you adapting your biologics strategies to focus on cell and gene therapies?
- What risk-sharing models drive biologics growth?
Transformation of Diagnostics Lab Automation and Monitoring Solutions
- Are you using modern sequencing to enhance diagnostics in oncology, prenatal, and infectious diseases?
- How are partnerships with diagnostics vendors boosting lab productivity?
- How does digitization help labs meet consumer demands for convenience?
Strategic Partnerships Driving Growth in Remote Patient Monitoring (RPM)
- How to integrate RPM technology with existing IT infrastructure for remote monitoring?
- How do clinician-focused RPM devices differ from telehealth solutions?
- Why are consumer-grade wearables not widely accepted in clinical RPM?
Top Strategic Imperatives for Growth
Are you ready to embrace the transformation in the healthcare and life sciences industry and thrive in drug discovery and development, precision health, healthcare information technology, and sports medicine?
Top 10 Strategic Imperatives Driving Innovation in AI-Enhanced Drug Discovery and Development
- Identifying new growth opportunities and addressing the needs of an aging population.
- Navigating artificial intelligence (AI) ethics in healthcare for growth.
- Adopting quantum computing for drug discovery and achieving growth with disruptive technologies.
Top 10 Strategic Imperatives Shaping the Healthcare IT Landscape
- Harnessing growth prospects emerging from generative artificial intelligence (AI) in healthcare.
- Adopting best practices to grow with opportunities in digital patient engagement.
- Leveraging innovative business models to capitalize on the growth potential of interoperability software.
Top 10 Strategic Imperatives: Navigating the Sports Medicine Revolution with Technology
- Discovering growth opportunities driven by wearable health integration.
- Capitalizing on disruptive technologies like virtual reality in rehabilitation for growth.
- Optimizing growth strategies with industry convergence and artificial intelligence in physical therapy.
AI-Enhanced Drug Discovery and Development
Healthcare IT
Sports Medicine
Frost Radar and Growth Perspectives
Healthcare Data Interoperability
How does adopting middleware compare to using a single platform in terms of data management efficiency?
Laboratory Information Management Systems
Are you capitalizing on generative artificial intelligence integration to gain a competitive edge and grow?
Wound Management Strategies
Who are the key players, what technologies do they use, and how advanced are these technologies?
Life Science Instrumentation
What are the best, integrated solutions for workflow optimization? Are you addressing the demand for microscopy?
Patient Monitoring
What new vendors are offering innovative solutions like wearables and contactless monitoring?
Molecular Diagnostics
Is your organization leveraging opportunities in personalized medicine for a competitive edge and growth?
Blood Group Typing
How can your team develop innovative devices, enhance safety, and improve storage duration?
Biotechnology
Will disruptive technologies and portfolio realignment by big biopharma companies drive investments?
Transformational Journey Exclusives
What are the major growth opportunities driving the transformation of healthcare information technology, chronic care, and precision health?
Top Growth Opportunities in Retail Health
How aligned is your medical technology growth strategy with the evolving needs of your customers?
Explore Megatrends!
Top Growth Opportunities in the Patient Monitoring Industry
Are you leveraging the innovations, the industry is moving towards more efficient, patient-centric care models?
Seize Growth!
Artificial Intelligence (AI) in Clinical Trials: Accelerating Success
How is AI transforming clinical trials in terms of design, recruitment, management, and execution for improved efficiency?
Maximize Your Potential!
Top 10 Strategic Imperatives Shaping the Healthcare Information Technology (IT) Landscape
Are you addressing key challenges like cybersecurity and patient engagement to drive growth in healthcare IT?
Close the Growth Gaps!
Transforming Life Sciences and Diagnostics: Embrace the Future of Automation and Integration
What are the megatrends driving the shift towards intelligent, automated solutions in pathology?
Grow with Opportunities!
Frost Radar – Growth Opportunities Driving the Clinical-Grade Wearables Industry
How can integrating wearables into remote care models enhance early disease detection and patient outcomes?
Transform with Technology!
Partnering Events
6th Edition Biopharma Conclave
DATES: 3rd – 4th SEPTEMBER 2024
VENUE: SAHARA STAR, MUMBAI, INDIA
CPHI Conferences is pleased to present the 6th edition of Biopharma Conclave scheduled on 3 - 4 September 2024 in Sahara Star, Mumbai. This comprehensive 2-day conclave will have parallel conference sessions on Biosimilars & Biologics and Cell & Gene Therapy.
The event will bring over 300+ experts, researchers, industry leaders, and other stakeholders in the biopharmaceutical industry to share knowledge, discuss new trends and innovations, and network with peers. We have 50+ industry leaders, innovators, regulators, and academia present at the conference making it an epicenter for knowledge and experience sharing. The conference has two tracks: Biosimilars & Biologics and Cell and Gene Therapy. The conference also hosts an exclusive closed-door Biopharma Leader’s Roundtable inviting the top industry leaders to be a part of the conclave.
The Biosimilars and Biologics track is extensively spread over two days covering key aspects of Biosimilars: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization. The latest biosimilars like peptides, protein-based biosimilars, MABs, and ADCs are covered giving a holistic picture of the latest trends and developments in the biological world.
The Cell and Gene therapy track will emphasize the industry trends in Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization providing a 360-degree view of the booming cell and gene therapy. The track will cover the latest technologies like CAR-T cell therapy, the latest stem cell research techniques, clinical studies, and trials presented by the top industry leaders and researchers.
Precision Health
Growth Opportunities in the Pharmaceutical Industry
Join Paljit Sohal, Frost & Sullivan, and explore the major growth opportunities in the pharmaceutical industry.
Schedule a Growth Pipeline Dialog with our experts to dive into the growth priorities for your organization in 2024 and beyond:
Frost Perspectives
Are You Leveraging Growth Opportunities in Brain Health Supplements to Promote Cognitive Wellbeing?
In today’s post-pandemic world – rife with geopolitical chaos and uncertainty – the mental health crisis is more pronounced than ever. This is reflected in the soaring demand for brain health solutions across all demographics.
In response, the nutraceutical industry is developing innovative, accessible, and sustainable supplements to meet evolving consumer needs.
Is Your Retail Health Growth Strategy Aligning with the Evolving Needs of Your Customers?
Retail health clinics are thriving by offering convenience, affordability, and accessibility. With extended weekend hours, shorter wait times, direct access to prescriptions, and multiple locations, they are effectively meeting community needs.
These clinics are alleviating the strain on healthcare systems and urgent care facilities, particularly during physician shortages. Significant cost savings for uninsured patients are further driving the shift toward retail health services.
Transforming Chronic Care: Exploring Innovative Platforms for Data-Driven Solutions
The chronic disease management ecosystem is undergoing rapid digitalization, revolutionizing care with enhanced personalization and communication.
Mobile apps, wearables, and monitoring devices are streamlining management processes, fostering patient engagement, and generating valuable data for improved care and cost reduction.
ASCO 2024 Round-Up: Advancements in Biomarker-Driven Medicines, Cancer Vaccines, and AI Applications Paving the Way for Expansion of Precision Oncology
The sessions of the American Society of Clinical Oncology (ASCO) 2024 conference focused on this year’s theme – The Art and Science of Cancer Care: From comfort to cure.
A few of the interesting developments announced included the development of biomarker-driven medicines that have led the way in the therapy of lung and breast cancer, among other cancers, and the exciting future of cancer vaccines, particularly when paired with immunotherapy (immuno-oncology [I-O]).
Press Releases
- Life Sciences eCommerce
- Drug Discovery and Development
ZAGENO Recognized with Frost & Sullivan’s 2024 Global Customer Value Leadership Award for Transforming the Lab Supply Procurement Experience
Frost & Sullivan analyzed the life sciences eCommerce industry and, based on its findings, recognizes ZAGENO with the 2024 Global Customer Value Leadership Award.
ZAGENO combines superior digital tools and a strong online presence to address the challenges of procuring lab supplies with its superior lab supply ordering platform.
Aragen Life Sciences Ltd. receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery and Development Services
Frost & Sullivan has recognized Aragen Life Sciences, a world-class contract research, development, and manufacturing organization (CRDMO), with the 2024 Global Customer Value Leadership Award.
With nearly 25 years of experience, Aragen assists its global clients in various industries, such as pharmaceutical, biotech, and agrochemical, throughout the biopharmaceutical lifecycle, offering comprehensive solutions spanning small and large molecules.
Transformational Growth
How can Leaders and Companies Achieve Transformational Growth?
Fueling growth starts with a strategic approach comprising three key components: Growth Content, Growth Community, and Growth Coaching.
Growth Content aids in identifying top growth opportunities, Frost Radars, and best practices.
Growth Community offers a platform for networking and collaboration via innovation workshops and webinars.
Growth Coaching supports growth initiatives through executive coaching clinics, expert growth coaches, and ad hoc interactions.
Webinars
Our webinars are renowned among industry leaders for their thought-provoking sessions that foster collaboration and drive transformation. Join our upcoming webinars to discover how your organization can leverage new opportunities to enable transformational growth and thrive amid rising competitive intensity.
Featured
Best Practices Recognition
What are the top companies across various regions and industries in terms of leadership and innovation?
Economic Analytics
Macroeconomic growth opportunities of artificial intelligence: How can you thrive amidst transformation?
Business & Financial Services
Global embedded payments industry: Which growth opportunities showcase vast potential?